Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lou, Jiatao ^a   Ben, Suqin ^b,d   Yang, Guohua ^c   Liang, Xiaohui ^a   Wang, Xiaoqian ^a   Ni, Songshi ^b   Han, Baohui ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

^b NANTONG UNIVERSITY   (China)

^c Department of Research and Development   (China)

^d SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOLATE RECEPTOR;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CIRCULATING TUMOR CELL; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; LIGAND TARGETED POLYMERASE CHAIN REACTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VALIDITY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL COUNT; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKOCYTE REDUCTION PROCEDURES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; OLIGONUCLEOTIDE PROBES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84891954473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080458     Document Type: Article

References (43)

1. Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, et al. (2012) Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib. Clin Cancer Res 18: 2391-2401.
2. Nieva J, Wendel M, Luttgen MS, Marrinucci D, Bazhenova L, et al. (2012) High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol 9: 016004.
3. Yoon SO, Kim YT, Jung KC, Jeon YK, Kim BH, et al. (2011) TTF-1 mRNApositive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer 71: 209-216.
4. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, et al. (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-smallcell lung cancer. J Clin Oncol 29: 1556-1563.
5. Wu C, Hao H, Li L, Zhou X, Guo Z, et al. (2009) Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol 4: 30-36.
6. Devriese LA, Bosma AJ, van de Heuvel MM, Heemsbergen W, Voest EE, et al. (2012) Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer 75: 242-247.
7. Lankiewicz S, Rivero BG, Bocher O (2006) Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol Biotechnol 34: 15-27. (Pubitemid 44337216)
8. Hayes DC, Secrist H, Bangur CS, Wang T, Zhang X, et al. (2006) Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res 26: 1567-1575.
9. Yamashita J, Matsuo A, Kurusu Y, Saishoji T, Hayashi N, et al. (2002) Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 124: 299-305. (Pubitemid 35025606)
10. Kurusu Y, Yamashita J, Ogawa M (1999) Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable nonsmall- cell lung cancer. Surgery 126: 820-826. (Pubitemid 29523318)
11. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, et al. (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377.
12. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904. (Pubitemid 39383039)
13. Allan AL, Vantyghem SA, Tuck AB, Chambers AF, Chin-Yee IH, et al. (2005) Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A 65: 4-14. (Pubitemid 40604981)
14. Vona G, Sabile A, Louha M, Sitruk V, Romana S, et al. (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156: 57-63. (Pubitemid 30644439)
15. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
16. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, et al. (2005) Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11: 3678-3685. (Pubitemid 40685584)
17. Naume B, Borgen E, Tossvik S, Pavlak N, Oates D, et al. (2004) Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Cytotherapy 6: 244-252. (Pubitemid 38868097)
18. Cruz I, Ciudad J, Cruz JJ, Ramos M, Gomez-Alonso A, et al. (2005) Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 123: 66-74. (Pubitemid 40066172)
19. He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, et al. (2008) Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer 123: 1968-1973.
20. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, et al. (2004) A rare-cell detector for cancer. Proc Natl Acad Sci U S A 101: 10501-10504. (Pubitemid 38955770)
21. Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, et al. (2005) Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 43: 617-627. (Pubitemid 41460612)
22. Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, et al. (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 7: 306-315.
23. Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, et al. (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J Clin Oncol 25: 5194-5202. (Pubitemid 350232250)
24. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, et al. (2002) Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20: 3404-3412.
25. Audic Y, Hartley RS (2004) Post-transcriptional regulation in cancer. Biol Cell 96: 479-498.
26. Crowe DL (1993) Retinoic acid mediates post-transcriptional regulation of keratin 19 mRNA levels. J Cell Sci 106 (Pt 1): 183-188. (Pubitemid 23286790)
27. Su L, Morgan PR, Lane EB (1996) Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. Hum Pathol 27: 800-806.
28. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, et al. (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338: 284-293. (Pubitemid 40312593)
29. O'Shannessy DJ, Yu G, Smale R, Fu YS, Singhal S, et al. (2012) Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget 3: 414-425.
30. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, et al. (2012) High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol 7: 833-840.
31. Christoph DC, Asuncion BR, Hassan B, Tran C, Maltzman JD, et al. (2013) Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed. J Thorac Oncol 8: 19-30.
32. Oremek GM, Sauer-Eppel H, Bruzdziak TH (2007) Value of tumour and inflammatory markers in lung cancer. Anticancer Res 27: 1911-1915. (Pubitemid 46954697)
33. Brechot JM, Chevret S, Nataf J, Le Gall C, Fretault J, et al. (1997) Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur J Cancer 33: 385-391. (Pubitemid 27168063)
34. Pujol JL, Boher JM, Grenier J, Quantin X (2001) Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer 31: 221-231. (Pubitemid 32109238)
35. Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, et al. (1995) Cyfra 21- 1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest 108: 163-169.
36. Iwakiri S, Sonobe M, Nagai S, Hirata T, Wada H, et al. (2008) Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol 15: 889-899.
37. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, et al. (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27: 49-57.
38. Reddy JA, Haneline LS, Srour EF, Antony AC, Clapp DW, et al. (1999) Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood 93: 3940-3948. (Pubitemid 29249843)
39. He W, Wang H, Hartmann LC, Cheng JX, Low PS (2007) In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A 104: 11760-11765. (Pubitemid 47175086)
40. Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, Samaniego R, Corcuera MT, et al. (2009) Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69: 9395-9403.
41. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, et al. (2007) Nonenzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282: 5691-5703. (Pubitemid 47093757)
42. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, et al. (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci U S A 86: 6454-6458. (Pubitemid 19236298)
43. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791. (Pubitemid 39095313)